Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease

Cellular Immunology

Volumn 237, Issue 1, 2005, Pages 68-75

  Secor Jr , Eric R ^a   Carson IV, William F ^a   Cloutier, Michelle M ^a,b   Guernsey, Linda A ^a   Schramm, Craig M ^a   Wu, Carol A ^a   Thrall, Roger S ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b Farmington   (United States)

Author keywords

Airway inflammation; Asthma; CD4+ T cells; Cysteine protease; IL 13; Immunomodulation

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIINFLAMMATORY AGENT; BROMELAIN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 13; OVALBUMIN; SODIUM CHLORIDE;

AEROSOL; AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HYPERSENSITIVITY; IMMUNOMODULATION; LEUKOCYTE; LUNG; LUNG LAVAGE; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD44; BROMELAINS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HYPERSENSITIVITY; MICE; MICE, INBRED C57BL; OVALBUMIN;

ANANAS COMOSUS; ANIMALIA; MURINAE;

EID: 29244447358     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.10.002     Document Type: Article

References (42)

1. C. Walker, M.K. Kaegi, P. Braun, and K. Blaser Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity J. Allergy Clin. Immunol. 88 1991 935 942
2. G. Caramori, A. Pandit, and A. Papi Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease? Curr. Opin. Allergy Clin. Immunol. 5 2005 77 83
3. I. Tillie-Leblond, P. Gosset, and A.B. Tonnel Inflammatory events in severe acute asthma Allergy 1 2005 23 29
4. J.D. Kennedy, C.A. Hatfield, S.F. Fidler, G.E. Winterrowd, J.V. Haas, J.E. Chin, and I.M. Richards Phenotypic characterization of T lymphocytes migrating into the lung tissue and airway lumen after antigen inhalation in sensitized mice Am. J. Respir. Cell Mol. Biol. 12 1995 613 623
5. J.A. Gonzalo, C.M. Lloyd, L. Kremer, E. Finger, C. Martinez, M.H. Siegelman, M. Cybulsky, and J.C. Gutierrez-Ramos Eosinophil recruitment to the lung in a mouse model of allergic inflammation. The role of T cells, chemokines and adhesion molecules J. Clin. Invest. 98 1996 2332 2345
6. H. Renz, R. Smith, J.E. Henson, B.S. Ray, C.G. Irvin, and E.W. Gelfand Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse J. Allergy Clin. Immunol. 89 1992 1127 1138
7. P.G. Holt, A.H. Rose, J.E. Batty, and K.J. Turner Induction of adjuvant-independent IgE responses in bred mice: primary, secondary and persistent IgE responses to ovalbumin and ovomucoid Int. Arch. Allergy Appl. Immun. 65 1981 42 50
8. T.T. Kung, H. Jones, G.K. Adams, S.P. Umland, W. Kreutner, R.W. Egan, R.W. Chapman, and A.S. Watnick Characterization of a murine model of allergic pulmonary inflammation Int. Arch. Allergy Immunol. 105 1994 83 90
9. C.A. Yiamouyiannis, C.M. Schramm, L. Puddington, P. Stengel, E. Baradaran-Hosseini, W.W. Wolyniec, H.E. Whiteley, and R.S. Thrall Shifts in lung lymphocyte profiles correlate with the sequential development of acute allergic and chronic tolerant stages in a murine asthma model Am. J. Pathol. 154 1999 1191 1921
10. C.M. Schramm, L. Puddington, C.A. Yiamouyiannis, E.G. Lingenheld, H.E. Whiteley, W.W. Wolyniec, T.C. Noonan, and R.S. Thrall Proinflammatory roles of T-cell receptor (TCR) gamma delta and TCR alpha beta lymphocytes in a murine model of asthma Am. J. Respir. Cell. Mol. Biol. 2 2000 218 225
11. C.M. Schramm, L. Puddington, C. Wu, L. Guernsey, M. Gharaee-Kermani, S.H. Phan, and R.S. Thrall Chronic inhaled ovalbumin exposure induces antigen-dependent but not antigen-specific inhalational tolerance in a murine model of allergic airway disease Am. J. Pathol. 1 2004 295 304
12. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia Am. J. Respir. Cell. Mol. Biol. 10 1994 587 593
13. G.S. Kelly Bromelain: a literature review and discussion of its therapeutic applications Altern. Med. Rev. 1 1996 243 257
14. H.R. Maurer Bromelain: biochemistry, pharmacology and medical use Cell. Mol. Life Sci. 58 2001 1231 1245
15. S.J. Taussig, and S. Batkin Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update J. Ethnopharmacol. 22 1988 191 203
16. W.M. Cooreman, S. Scharpe, J. Demeester, and A. Lauwers Bromelain, biochemical and pharmacological properties Pharm. Acta Helv. 4 1976 73 97
17. K.I. Izaka, M. Yamada, T. Kawano, and T. Suyama Gastrointestinal absorption and anti-inflammatory effect of bromelain Jpn. J. Pharmacol. 4 1972 519 534
18. L.P. Hale, P.K. Greer, C.T. Trinh, and M.R. Gottfried Treatment with oral bromelain decreases colonic inflammation in the IL-10 deficient murine model of inflammatory bowel disease Clin. Immunol. 5 2005 783 793
19. R. Jaber Respiratory and allergic diseases: from upper respiratory tract infections to asthma Prim. Care 2 2002 231 261
20. T.L. Mynott, A. Ladhams, P. Scarmato, and C.R. Engwerda Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells J. Immunol. 163 1999 2568 2575
21. C.R. Engweda, D. Andrew, A. Ladhams, and T.L. Mynott Bromelain modulates T cell and B cell immune responses in vitro and in vivo Cell. Immunol. 210 2001 66 75
22. K. Eckert, E. Grabowska, R. Stange, U. Schneider, K. Eschmann, and H.R. Maurer Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients Oncol. Rep. 6 1999 1191 1199
23. L.P. Hale, P.K. Greer, and G.D. Sempowski Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation Clin. Immunol. 104 2002 183 190
24. + cells and the interferon-gamma response in Peyer's patches and spleen in endotoxemic balb/c mice Cell. Immunol. 2 2002 113 119
25. J. Li, H. Saito, L. Crawford, M.D. Inman, M.M. Cyr, and J.A. Denburg Haemopoietic mechanisms in murine allergic upper and lower airway inflammation Immunology 114 2005 386 396
26. M.B. Hogan, D.N. Weissman, A.F. Hubbs, L.F. Gibson, D. Piktel, and K.S. Landreth Regulation of eosinophilopoiesis in a murine model of asthma J. Immunol. 171 2003 2644 2651
27. C. Taube, A. Dakhama, and E.W. Gelfand Insights into the pathogenesis of asthma utilizing murine models Arch. Allergy Immunol. 135 2004 173 186
28. H.C. DeGrendele, P. Estess, L.J. Picker, and M.H. Siegelman CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway J. Exp. Med. 183 1996 1119 1130
29. H.C. DeGrendele, P. Estess, and M.H. Siegelman Requirement for CD44 in activated T cell extravasation into an inflammatory site Science 278 1997 672 675
30. N.A. Lee, E.W. Gelfand, and J.J. Lee Pulmonary T cells and eosinophils: co-conspirators or independent triggers of allergic respiratory pathology? J. Allergy Clin. Immunol. 107 2001 945 957
31. Y. Ohkawara, G. Tamura, T. Iwasaki, A. Tanaka, and K. Shirato Activation and transforming growth factor-β production in eosinophils by hyaluronan Am. J. Respir. Cell. Mol. Biol. 23 2000 444 451
32. O.S. Targoni, M. Tary-Lehmann, and P.V. Lehmann Prevention of murine EAE by oral hydrolytic enzyme treatment J. Autoimmune 12 1999 191 198
33. L.P. Hale Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice Int. Immunopharmacol. 2 2004 255 264
34. B.B. Tysnes, H.R. Maurer, T. Porwol, B. Probst, R. Bjerkvig, and F. Hoover Bromelain reversibly inhibits invasive properties of glioma cells Neoplasia 6 2001 2469 2479
35. R. Kleef, T.M. Delohery, and D.H. Bovbjerg Selective modulation of cell adhesion molecules on lymphocytes by bromelain protease Pathobiology 64 1996 339 346
36. J.V. Castell, G. Friedrich, C.S. Kuhn, and G.E. Poppe Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake Am. J. Physiol. 273 1997 139 146
37. H.P. Ammon Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases Wien. Med. Wochenschr. 152 2002 373 378
38. M. Lemay, M.A. Murray, A. Davies, H. Roh-Schmidt, and R.K. Randolph In vitro and ex vivo cyclooxygenase inhibition by a hops extract Asia Pac. J. Clin. Nutr. 13 2004 S110
39. S. Darshan, and R. Doreswamy Patented antiinflammatory plant drug development from traditional medicine Phytother. Res. 18 2004 343 357
40. S.K. Katiyar Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects Int. J. Oncol. 26 2005 169 176
41. L. Bielory Complementary and alternative interventions in asthma, allergy, and immunology Ann. Allergy Asthma Immunol. 93 2004 S45 S54
42. J.A. Kralovec, M.R. Power, F. Liu, E. Maydansk, H.S. Ewart, L.V. Watson, C.J. Barrow, and T.J. Lin An aqueous Chlorella extract inhibits IL-5 production by mast cells in vitro and reduces ovalbumin-induced eosinophil infiltration in the airway in mice in vivo Int. Immunopharmacol. 4 2005 689 698